The Psychopharmacology Treatment Planner provides all the elements necessary to quickly and easily develop formal treatment plans that satisfy the demands of HMOs, managed care companies, third-party payors, and state and federal review agencies.  Saves you hours of time-consuming paperwork, yet offers the freedom to develop customized treatment plans for clients whose therapy includes psychotropic drugs Organized around 28 main presenting problems regularly treated with a combination of psychotropic and psychotherapeutic interventions or treatment modalities, from ADHD, dementia, and substance abuse to antisocial behavior, bipolar disorders, and more Over 1,000 well-crafted, clear statements describe the behavioral manifestations of each relational problem, long-term goals, short-term objectives, and clinically tested treatment options Easy-to-use reference format helps locate treatment plan components by behavioral problem or DSM-IV-TR(TM) diagnosis Includes a sample treatment plan that conforms to the requirements of most third-party payors and accrediting agencies (including HCFA, JCAHO, and NCQA)

The Psychopharmacology Treatment Planner

Health, Fitness & Dieting

Charles B. Nemeroff

Arthur E. Jongsma, Jr.

David C. Purselle

Psychology & Counseling

wiley

Bringing together the research studies of more than 30 research psychiatrists and scientists, "Neuropeptides and Psychiatric disorders" examines the recent advances in the neurobiology of neuropeptides and their importance in the pathogenesis of the major psychiatric disorders including depression and schizophrenia. Each chapter in this volume covers a particular neuropeptide and discusses in detail their role in psychiatric disorders. In Chapter 1, the author provides the reader with a brief introduction to the neurobiology of neuropeptides. In Chapter 3, the contributors review the evidence that alterations in the brain of CSF somatostatin might reflect or contribute to the pathophysiology of several neuropsychiatric disorders, particularly Alzheimer's disease and depression. Chapter 6, briefly summarize an extensive literature of studies of the anterior pitutiary hormone growth hormone in various psychiatric disease states and then focuses on more recent studies of the role of the 44-amino acid hypothalamic peptide, human growth hormone-releasing factor (HGRF) in the pathophysiology of growth hormone disturbances in the psychiatric illness. Chapter 8, suggests that oxytocin may affect human behaviour and psychopathology. The chapter begins with an overview of oxytocin systems in the brain with an emphasis on findings that have psychiatric implications, and concludes by summarizing the evidence for the role of oxytocin in major affective disorders as well as psychiatric disorders associated with changes in female reproductive states. Two peptides are examined in Chapter 13. Neuropeptide Y (NPY), and delta sleep-inducing peptide are both involved in a number of central nervous system actions, and possibly also in neuropsychiatric illnesses. Chapter 14, discusses and critiques the techniques that are available to study receptors. Such methods as the use of antibody and molecular biological techniques which represent the future directions for studying receptors are also discussed. To conclude, Chapter 15 reviews clinical findings as well as findings using neuroendocrine and peptide challenge tests in patients with primary and secondary affective disorders with and without organic factors presumed to be etiologic in the affective syndromes.

Neuropeptides and Psychiatric Disorders (Progress in Psychiatry)

Amer Psychiatric Pub Inc

Book by Nemeroff, Charles B. and Prange, Arthur J. Jr. (Eds)

Neurotensin, a brain and gastrointestinal peptide (Annals of the New York Academy of Sciences)

Arthur J. Prange

New York Academy of Sciences

Annals of the New York Academy of Sciences vol 537

The Mesocorticolimbic dopamine system (Annals of the New York Academy of Sciences)

Stanford Univ., CA. Synopsis and update on clinically relevant material from The American Psychiatric Press Textbook of Psychopharmacology, 2nd ed., c1998. Also includes new data based on recent literature since publication of the Textbook. Provides specific data about drug selection and prescribing practices. Softcover. DNLM: Mental Disorders--drug therapy.

Essentials of Clinical Psychopharmacology

Medical Books

Alan F. Schatzberg

Pharmacology

Study Guide to Psychopharmacology is a question-and-answer companion that allows you to evaluate your mastery of the subject matter as you progress through The American Psychiatric Publishing Textbook of Psychopharmacology, Fourth Edition. The Study Guide is made up of 368 questions divided into 67 individual quizzes of 5 10 questions each that correspond to chapters in the Textbook. Questions are followed by an Answer Guide that references relevant text (including the page number) in the Textbook to allow quick access to needed information. Each answer is accompanied by a discussion that not only addresses the correct response but also explains why other responses are not correct. The Study Guide's companion, The American Psychiatric Publishing Textbook of Psychopharmacology, has been updated to keep you current with the latest research and trends in the field. Covering both basic science and clinical practice, this new edition draws on the talents of 53 new contributors to guarantee fresh, authoritative perspectives on advances in psychiatric drug therapy.

Psychopharmacology: Study Guide to Psychopharmacology: a Companion to the American Psychiatric Publishing Textbook of Psychopharmacology

Robert E. Hales

Narriman C. Shahrokh

American Psychiatric Publishing, Inc.

The American Psychiatric Association Publishing Textbook of Psychopharmacology boasts a long and unassailable reputation as a classic, providing a clearly written, meticulously cross-referenced, and user-friendly guide to this swiftly evolving field. This new 5th Edition has been thoroughly updated in the context of the latest research and reflects the introduction of DSM-5. The chapter authors were carefully selected for their expertise, and the editors have ensured that the resulting text is consistent in style and approach across topics and sections. The journey beginning with the core principles of molecular biology, genetics and genomics, and pharmacokinetics, continuing with the myriad classes of psychopharmacological agents, and ultimately arriving at the treatment of major psychiatric disorders as well as of specific age groups and circumstances is logical, easy to follow, and authoritative.
Both physicians still in training and clinicians who regularly prescribe psychotropic medications will find the up-to-date and specific guidance on drug selection invaluable. The American Psychiatric Association Publishing Textbook of Psychopharmacology remains an essential, and trusted, companion.

The American Psychiatric Association Publishing Textbook of Psychopharmacology

Amer Psychiatric Pub

American Psychiatric Association Publishing

See the best price to sell, buy, or rent books by Charles B. Nemeroff. BookScouter helps to compare book prices from 25+ online bookstores and 30+ buyback vendors with a single search.

Books by Charles B. Nemeroff

See the best price to sell, buy, or rent books by Charles B. Nemeroff. BookScouter helps to compare book prices from 25+ online bookstores and 30+ buyback vendors with a single search.

The Psychopharmacology Treatment Planner

Neuropeptides and Psychiatric Disorders (Progress in Psychiatry)

Neurotensin, a brain and gastrointestinal peptide (Annals of the New York Academy of Sciences)

The Mesocorticolimbic dopamine system (Annals of the New York Academy of Sciences)

Essentials of Clinical Psychopharmacology

Psychopharmacology: Study Guide to Psychopharmacology: a Companion to the American Psychiatric Publishing Textbook of Psychopharmacology

The American Psychiatric Association Publishing Textbook of Psychopharmacology

The American Psychiatric Association Publishing Textbook of Psychopharmacology